|drug1255||Facial mask Wiki||1.00|
|D003141||Communicable Diseases NIH||0.07|
|D045169||Severe Acute Respiratory Syndrome NIH||0.04|
There is one clinical trial.
The COVID-19 pandemic health crisis forces health institutions to lower their standards of protection as supplies of personal protective equipment decrease despite the safety of front-line workers worldwide . This shortage specifically affects high-quality protective masks, such as those called FFP2. As alternatives, we offer a reusable mask based on a ventilation mask combined with a breathing filter for anesthesia breathing circuits. The purpose of the study is to assess the sealing potential of this mask in the field and possibly prove a non-inferior sealing compared to standard masks type FFP2.
Description: Non inferiority claim over FFP2Measure: Evaluation of airtightness (Fit test) Time: Up to 1 week
Description: User face comfort for each type of mask assessed by a assessed by a scoring-cale from 1 to 5Measure: User Comfort Time: Up to 1 week
Description: User respiratory easiness for each type of mask assessed by a scoring-cale from 1 to 5Measure: Breathing easiness Time: Up to 1 week
Description: User field of view quality for each type of mask assessed by a scoring-cale from 1 to 5Measure: Field of view quality Time: Up to 1 week
Description: How the device is user friendly, assessed by a scoring-cale from 1 to 5Measure: Ease of use Time: Up to 1 week
Data processed on December 13, 2020.
An HTML report was created for each of the unique drugs, MeSH, and HPO terms associated with COVID-19 clinical trials. Each report contains a list of either the drug, the MeSH terms, or the HPO terms. All of the terms in a category are displayed on the left-hand side of the report to enable easy navigation, and the reports contain a list of correlated drugs, MeSH, and HPO terms. Further, all reports contain the details of the clinical trials in which the term is referenced. Every clinical trial report shows the mapped HPO and MeSH terms, which are also hyperlinked. Related HPO terms, with their associated genes, protein mutations, and SNPs are also referenced in the report.Drug Reports MeSH Reports HPO Reports